Xcovery Company Profile
Xcovery is a clinical-stage company focused on the development of next-generation targeted therapeutics for cancer. Founded by Sheridan G. Snyder and Chris Liang, PhD, Xcoveryâs vision is to successfully develop innovative oncology therapies to optimize patient outcomes. Through innovative drug design, Xcovery has developed a comprehensive pipeline of oncology therapies that target a wide range of advanced tumors. X-82, currently in Phase 1 clinical trials, was developed by Tyrogenex, an Xcovery company, funded by Biocatalyst International.
News Articles
Xcovery Holdings Raises $6M in Series B Financing; Xcovery Vision Set to Begin Phase I/II ...
First Clinical Trial of an Oral Angiogenesis Inhibitor for the Treatment of Neovascular "Wet" AMD Read more...
Xcovery completes venture financing
Xcovery Appoints Expert in Targeted Cancer Therapeutics
Xcovery, a clinical-stage company focused on the development of next-generation targeted therapeutics for cancer, today announced that Dr. Samuel Broder has been appointed Senior...
Xcovery Presents Phase 1 Clinical Results at ASCO Annual Meeting
WEST PALM BEACH, FL and CHICAGO, IL -- (Marketwire) -- 06/04/12 -- Xcovery, a developer of next-generation targeted therapeutics for cancer, today announced preliminary data presented from its Phase...
XCOVERY PRESENTS PHASE 1 CLINICAL RESULTS AT ASCO ANNUAL MEETING
Study is First-in-Human Trial of an Oral VEGFR Tyrosine Kinase Inhibitor (TKI) in Patients with Advanced Solid Tumors
Xcovery set to begin Phase I/II AMD trial with oral drug candidate
Xcovery Holdings starts Phase I/II trials of oral angiogenesis inhibitor, X-82, for neovascular wet age-related macular degeneration (AMD).
Start-Up Previews, October 2012
This Month's Profile Group: New Orals, Better Topicals Top Psoriasis Wish List, features profiles of Avexxin, Cellceutix, Convoy Therapeutics, and Creabilis. Plus these Start-Ups Across Health Care: D...
These days, almost all cancers are treated with more than a single drug; the combinations typically include some type of chemotherapy and where possible an agent targeted at a particular mechanism kno...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
Xcovery Vision is an ophthalmology-focused subsidiary of Xcovery Holding, a clinical-stage company developing novel therapies for cancer and inflammatory diseases. Xcovery Vision'...
Xcovery is a clinical-stage company focused on the development of next-generation targeted therapeutics for cancer. Founded by Sheridan G. Snyder and Chris Liang, PhD, Xcoveryâ...
More Information about "Xcovery" on BioPortfolio
We have published hundreds of Xcovery news stories on BioPortfolio along with dozens of Xcovery Clinical Trials and PubMed Articles about Xcovery for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Xcovery Companies in our database. You can also find out about relevant Xcovery Drugs and Medications on this site too.
